Assessment of effectiveness of a COVID-adapted diagnostic pathway for colorectal cancer to mitigate the adverse impact on investigation and referrals
Janice Miller, Yasuko Maeda, Stephanie Au, Frances Gunn, Lorna Porteous, Rebecca Pattenden, Peter MacLean, Colin L Noble, Stephen Glancy, Malcolm G Dunlop, Farhat V N Din
doi: https://doi.org/10.1101/2020.11.23.20236778
Janice Miller
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
2Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, EH16 4SA
MDYasuko Maeda
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
2Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, EH16 4SA
MPhilStephanie Au
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
MScFrances Gunn
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
RNLorna Porteous
3Lead GP for cancer and palliative care, NHS Lothian, Edinburgh, EH1 3EG
MBChBRebecca Pattenden
4Department of Biochemistry, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
MScPeter MacLean
5Department of Radiology, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
FRCRColin L Noble
6Department of Gastroenterology, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
MDStephen Glancy
5Department of Radiology, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
FRCRMalcolm G Dunlop
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
2Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, EH16 4SA
FRSEFarhat V N Din
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
2Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, EH16 4SA
MDData Availability
De-identified data is available from the corresponding author on request.
Posted November 24, 2020.
Assessment of effectiveness of a COVID-adapted diagnostic pathway for colorectal cancer to mitigate the adverse impact on investigation and referrals
Janice Miller, Yasuko Maeda, Stephanie Au, Frances Gunn, Lorna Porteous, Rebecca Pattenden, Peter MacLean, Colin L Noble, Stephen Glancy, Malcolm G Dunlop, Farhat V N Din
medRxiv 2020.11.23.20236778; doi: https://doi.org/10.1101/2020.11.23.20236778
Assessment of effectiveness of a COVID-adapted diagnostic pathway for colorectal cancer to mitigate the adverse impact on investigation and referrals
Janice Miller, Yasuko Maeda, Stephanie Au, Frances Gunn, Lorna Porteous, Rebecca Pattenden, Peter MacLean, Colin L Noble, Stephen Glancy, Malcolm G Dunlop, Farhat V N Din
medRxiv 2020.11.23.20236778; doi: https://doi.org/10.1101/2020.11.23.20236778
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2338)
- Dermatology (205)
- Emergency Medicine (374)
- Epidemiology (11707)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3690)
- Geriatric Medicine (346)
- Health Economics (632)
- Health Informatics (2368)
- Health Policy (926)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3455)
- Nursing (195)
- Nutrition (520)
- Oncology (1804)
- Ophthalmology (533)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6092)
- Radiology and Imaging (1260)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (145)